MLTX Q2 2025 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$742,000

Operating Income

-$61M

Net Income

-$55M

EPS (Diluted)

$-0.87

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$55M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$460M

Total Liabilities

$102M

Stockholders' Equity

$354M

Cash & Equivalents

$307M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$742,000	$0	—
Operating Income	-$61M	-$31M	-98.5%
Net Income	-$55M	-$24M	-127.6%

Revenue Segments

License

$300M100%